Metformin reduces circulating malondialdehyde-modified low-density lipoprotein in type 2 diabetes mellitus
نویسندگان
چکیده
منابع مشابه
Metformin reduces circulating malondialdehyde-modified low-density lipoprotein in type 2 diabetes mellitus.
PURPOSE Type 2 diabetes is known to be associated with increasing cardiovascular mortality. Malondialdehyde-modified LDL (MDA-LDL) is an oxidized LDL and is increased in patients with diabetes or hypertriglyceridemia. Elevated MDA-LDL has been reported to be a risk factor of atherosclerosis or cardiovascular disease. Sitagliptin is a dipeptidyl peptidase-4 inhibitor and a new class of hypoglyce...
متن کاملSoluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus.
The lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) can be proteolytically cleaved and released as soluble forms (sLOX-1). We have determined serums LOX-1 in type 2 diabetes and evaluated the effect of glucose and advanced glycation end products (AGEs) on sLOX-1 in vitro and in vivo. Endothelial cells were incubated with glucose or AGEs, and sLOX-1 in cell medium was measured. S...
متن کاملAtorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis.
BACKGROUND AND OBJECTIVES Patients undergoing maintenance hemodialysis are at high cardiovascular risk. Lowering LDL-cholesterol with statins reduces the incidence rate of cardiovascular events in patients with chronic kidney disease. In contrast, two randomized, prospective, placebo-controlled trials have been completed in hemodialysis patients that showed no significant effects of statins on ...
متن کاملTargeting low-density lipoprotein and dysmetabolism in type 2 diabetes mellitus.
D iabetes mellitus affects 28.5 million people in the United States with another 79 million people having prediabetes at high risk for developing diabetes mellitus, 1 despite current preventive efforts using lifestyle or antidiabetic agents such as metformin. 2 Because cardiovascular disease (CVD) is the major cause of death and disability in diabetes mellitus, and its impact on health remains ...
متن کاملLowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is characterized by hyperglycemia, insulin resistance, and/or progressive loss of β-cell function. T2DM patients are at increased risk of micro- and macrovascular disease, and are often considered as representing an atherosclerotic coronary heart disease (CHD) risk equivalent. Interventions directed at glucose and lipid level control in T2DM patients may reduce m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical & Investigative Medicine
سال: 2014
ISSN: 1488-2353
DOI: 10.25011/cim.v37i4.21730